Institutional investors purchased a net $667.5 thousand shares of ENZ during the quarter ended July 2015. This may signal that the smart money is gaining interest in this company as the 54.46% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIRST LIGHT ASSET MANAGEMENT LLC Bought 786.7 Thousand shares of Enzo Biochem Inc
LONE STAR VALUE MANAGEMENT LLC Bought 729.0 Thousand shares of Enzo Biochem Inc